Zimmer Biomet Holdings, Inc. (ZBH)
| Market Cap | 32.80B |
| Revenue (ttm) | 7.06B |
| Net Income (ttm) | -151.90M |
| Shares Out | 207.10M |
| EPS (ttm) | -0.74 |
| PE Ratio | n/a |
| Forward PE | 20.37 |
| Dividend | $0.96 |
| Dividend Yield | 0.63% |
| Trading Day | January 27 |
| Last Price | $152.60 |
| Previous Close | $158.22 |
| Change ($) | -5.62 |
| Change (%) | -3.55% |
| Day's Open | 155.23 |
| Day's Range | 152.02 - 157.72 |
| Day's Volume | 1,890,046 |
| 52-Week Range | 79.99 - 163.46 |
STOCKHOLM, Jan. 21, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the...
WARSAW, Ind., Jan. 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ellison (Ellie) M. Humphrey ha...
Final Trades: Pfizer, Devon Energy, Zimmer & more
The "Halftime Report" traders give their top picks to watch for the second half.
WARSAW, Ind., Jan. 8, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 5, 2...
Zimmer Biomet (ZBH) is performing well in its priority areas like quality remediation, supply recovery efforts and product introductions.
Final Trades: Home Depot, Zimmer Holdings, Tractor Supply & more
The "Halftime Report" traders give their top picks to watch for the second half.
Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.
WARSAW, Ind., Dec. 16, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has app...
WARSAW, Ind., Dec. 14, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson...
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Marvell and Campbell Soup.
Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.
Let's see if Zimmer Biomet (ZBH) stock is a good choice for value-oriented investors right now from multiple angles.
The benefits of reopening post-pandemic have not yet been factored in for these four stocks relative to their earnings, according to UBS analysts.
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
This latest development aligns with Zimmer Biomet's (ZBH) active portfolio management strategy and the ongoing transformation of business aimed at long-term growth.
LOS ANGELES--(BUSINESS WIRE)--Vance Street Capital LLC (“Vance Street”) is pleased to announce it has completed the sale of A&E Medical Corporation (“A&E Medical”) to Zimmer Biomet (NYSE: ZBH)...
WARSAW, Ind., Dec. 1, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today officially launched the Zimmer Biomet Foundati...
Zimmer Biomet has exited the 3rd quarter better than expected, with tailwinds in hips and knees globally to drive top-line growth in years to come. The ROSA and Persona Revision segments have ...
Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q3 2020 Results - Earnings Call Transcript
The company's recovery from the coronavirus pandemic was better than expected.
Zimmer Biomet (ZBH) registers stronger-than-expected recovery of elective procedures in the third quarter.
Zimmer (ZBH) delivered earnings and revenue surprises of 72.38% and 12.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Zimmer Biomet Holdings (NYSE:ZBH) were unchanged after the company reported Q3 results.
WARSAW, Ind., Nov. 6, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2020. The Company reported thir...
WARSAW, Ind., Nov. 5, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced preliminary results from a prospecti...
Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how ZBH, HRC and HMS are poised ahead of their announcements.
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, on the back of several factors.
Zimmer Biomet's (ZBH) Dental product volumes are expected to have declined significantly in the third quarter due to the extremely elective nature of the products.
WARSAW, Ind., Nov. 2, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that President and CEO Bryan Hanson and Ex...
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Final Trades: Starbucks, Facebook, Zimmer Holdings & more
The "Halftime Report" traders give their top picks to watch for the second half.
WARSAW, Ind., Oct. 6, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Friday, November 6, 20...
While technology has been the engine that has driven stock market performance for some time now, increasingly we are seeing a seismic shift to health care among many portfolio managers, and wi...
WARSAW, Ind., Sept. 10, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.
WARSAW, Ind., Sept. 8, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Let us delve deeper to get an insight into the not-so-talked-about but intense threats to MedTech.
Final Trades: Zimmer Holdings, Berkshire Hathaway, XPO Logistics & more
The "Halftime Report" traders give their top picks to watch for the second half.
Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q2 2020 Results - Earnings Call Transcript
Zimmer Biomet's (ZBH) second-quarter elective procedure volumes decline across all regions.
Zimmer (ZBH) delivered earnings and revenue surprises of 106.94% and 31.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
WARSAW, Ind., Aug. 4, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zimmer Biomet's (ZBH) Hips and Knees portfolios are expected to have contributed to second-quarter top line despite pandemic-led business disruptions.
Zimmer Biomet Holdings Inc (NASDAQ: ZBH) shares are trading higher on Wednesday after SVB Leerink maintained a Buy rating on the stock and raised its price target from $136 to $146.
The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.
About ZBH
Zimmer Biomet Holdings, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma pr... [Read more...]
| Industry Medical Devices | Founded 1927 |
| CEO Bryan Hanson | Employees 19,900 |
| Stock Exchange NYSE | Ticker Symbol ZBH |
Analyst Forecasts
According to 30 analysts, the average rating for Zimmer Biomet stock is "Buy." The 12-month stock price forecast is 168.30, which is an increase of 10.29% from the latest price.